Loading resource…

American College of Rheumatology
The guideline developed by the American College of Rheumatology aims to assist healthcare providers in managing antirheumatic medications during the perioperative period for patients undergoing elective total hip or knee arthroplasty. It outlines considerations for medication continuation or adjustment based on disease activity and surgical timing. The recommendations are based on the latest evidence and are intended to enhance patient outcomes while minimizing risks associated with medication management during surgery.
No account needed
Answers use this document only.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

NAVIGATING EVIDENCE-BASED RECOMMENDATIONS FOR THE MANAGEMENT OF SYSTEMIC SCLEROSIS
Same clinical topic · Rheumatology

2025 AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) GUIDELINE FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
Same clinical topic · Rheumatology

EVIDENCE-BASED GUIDELINE FOR THE DIAGNOSIS AND MANAGEMENT OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
Same clinical topic · Rheumatology

KDIGO 2023 CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS
Same clinical topic · Rheumatology

2026 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Axial Spondyloarthritis in Adults and Children/Adolescents
Same clinical topic · Rheumatology

Approach to a patient with joint pain
Same specialty · Rheumatology

Current Diagnosis & Treatment Rheumatology 4th Edition 2021
Same specialty · Rheumatology

Rheumatology secrets fourth edition
Same specialty · Rheumatology

PassMedicine 2025 Rheumatology part 2
Same specialty · Rheumatology